Boehringer Ingelheim Adopts Owkin's K Pro for AI Scientist
On September 2, Owkin announced a licensing agreement with Boehringer Ingelheim regarding its "AI Scientist." The pharmaceutical group thus joins AstraZeneca and Sanofi among the users of K Pro, the agency platform of the startup dedicated to the needs of researchers.
Licensing Agreement and New Users at Boehringer
On September 2, Owkin announced the signing of a licensing agreement with Boehringer Ingelheim concerning its "AI Scientist." This partnership brings the German pharmaceutical group into the list of users of K Pro, Owkin's agency platform, alongside AstraZeneca and Sanofi.
Le brief IA que les pros lisent chaque soir
Les 7 actus IA du jour, décryptées en 5 min. Gratuit.
Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.
Choisissez votre rythme
Gratuit · Pas de spam · Désabonnement en 1 clic
What K Pro Offers Research Teams
K Pro is an agency platform developed by Owkin, specializing in the application of artificial intelligence to pharmaceutical research. This solution orchestrates AI models and data to respond to researchers' queries, supporting their work in the pharmaceutical sector.
Brief IA — L'actualité IA en français
L'essentiel de l'actualité de l'intelligence artificielle, décrypté et expliqué chaque jour.